Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1053200.RALLs3MvwaHaM6XThWYJnVi--ExdPu240HEJzG4n-gWKE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1053200.RALLs3MvwaHaM6XThWYJnVi--ExdPu240HEJzG4n-gWKE130_assertion type Assertion NP1053200.RALLs3MvwaHaM6XThWYJnVi--ExdPu240HEJzG4n-gWKE130_head.
- NP1053200.RALLs3MvwaHaM6XThWYJnVi--ExdPu240HEJzG4n-gWKE130_assertion description "[Higher rates of point mutations and chromosomal translocations are found in aromatase inhibitor-resistant ER+ cancers and in the basal-like and HER2-enriched breast cancer subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053200.RALLs3MvwaHaM6XThWYJnVi--ExdPu240HEJzG4n-gWKE130_provenance.
- NP1053200.RALLs3MvwaHaM6XThWYJnVi--ExdPu240HEJzG4n-gWKE130_assertion evidence source_evidence_literature NP1053200.RALLs3MvwaHaM6XThWYJnVi--ExdPu240HEJzG4n-gWKE130_provenance.
- NP1053200.RALLs3MvwaHaM6XThWYJnVi--ExdPu240HEJzG4n-gWKE130_assertion SIO_000772 23411384 NP1053200.RALLs3MvwaHaM6XThWYJnVi--ExdPu240HEJzG4n-gWKE130_provenance.
- NP1053200.RALLs3MvwaHaM6XThWYJnVi--ExdPu240HEJzG4n-gWKE130_assertion wasDerivedFrom befree-2016 NP1053200.RALLs3MvwaHaM6XThWYJnVi--ExdPu240HEJzG4n-gWKE130_provenance.
- NP1053200.RALLs3MvwaHaM6XThWYJnVi--ExdPu240HEJzG4n-gWKE130_assertion wasGeneratedBy ECO_0000203 NP1053200.RALLs3MvwaHaM6XThWYJnVi--ExdPu240HEJzG4n-gWKE130_provenance.